| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,227 |
10,528 |
$970K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,914 |
13,408 |
$818K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,798 |
1,780 |
$173K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,378 |
1,369 |
$124K |
| 99442 |
|
2,021 |
1,891 |
$120K |
| 99385 |
|
594 |
584 |
$66K |
| 99408 |
|
3,752 |
3,720 |
$59K |
| 36415 |
Collection of venous blood by venipuncture |
11,535 |
10,980 |
$35K |
| 99386 |
|
217 |
214 |
$27K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,113 |
1,094 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
311 |
310 |
$25K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
1,107 |
1,086 |
$23K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,726 |
1,487 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
225 |
224 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
175 |
175 |
$16K |
| 81002 |
|
6,646 |
5,922 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,897 |
1,675 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
174 |
174 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
161 |
157 |
$13K |
| 99406 |
|
1,731 |
1,676 |
$11K |
| 96127 |
|
2,187 |
2,166 |
$6K |
| 99383 |
|
68 |
68 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
626 |
620 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
542 |
536 |
$5K |
| 90686 |
|
490 |
489 |
$4K |
| 99384 |
|
43 |
43 |
$4K |
| 90688 |
|
247 |
244 |
$4K |
| 92551 |
|
430 |
430 |
$3K |
| 97802 |
|
5,365 |
5,303 |
$2K |
| 93000 |
|
234 |
233 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
127 |
77 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
14 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
45 |
45 |
$2K |
| 99443 |
|
46 |
43 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
68 |
68 |
$912.21 |
| 81025 |
|
119 |
115 |
$837.82 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
82 |
80 |
$799.58 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
92 |
89 |
$793.47 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
359 |
322 |
$511.80 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,189 |
4,140 |
$406.32 |
| 69210 |
|
12 |
12 |
$285.80 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
1,844 |
1,821 |
$262.50 |
| 99051 |
|
98 |
93 |
$192.38 |
| 96160 |
|
49 |
49 |
$112.48 |
| 99441 |
|
15 |
12 |
$79.83 |
| 85018 |
|
30 |
30 |
$53.66 |
| 1111F |
|
5,754 |
5,292 |
$45.00 |
| 99050 |
|
21 |
18 |
$25.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,195 |
3,157 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
3,205 |
2,985 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
3,082 |
3,043 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
966 |
958 |
$0.00 |
| 99173 |
|
431 |
431 |
$0.00 |
| G9899 |
Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed |
447 |
437 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
112 |
111 |
$0.00 |
| 3725F |
|
164 |
155 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
260 |
259 |
$0.00 |
| 99401 |
|
388 |
388 |
$0.00 |
| G8731 |
Pain assessment using a standardized tool is documented as negative, no follow-up plan required |
50 |
49 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
54 |
50 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
40 |
39 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
129 |
129 |
$0.00 |
| 4004F |
|
13 |
13 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
12 |
12 |
$0.00 |
| 90461 |
|
16 |
16 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
13 |
13 |
$0.00 |
| 1036F |
|
3,939 |
3,900 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
63 |
63 |
$0.00 |
| 3017F |
|
1,617 |
1,599 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
3,533 |
3,372 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
2,008 |
1,988 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
634 |
597 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
98 |
91 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
204 |
203 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
132 |
128 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
223 |
216 |
$0.00 |
| 86580 |
|
113 |
113 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
171 |
169 |
$0.00 |
| 3074F |
|
12 |
12 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
13 |
13 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
30 |
29 |
$0.00 |